FdaApplication
ANDA 214464
Identifiers
- fda_app_no: ANDA214464
Properties
| Property | Value |
|---|---|
| applicant_name | RESPIRENT PHARMACEUTICALS CO LTD |
| application_type | ANDA |
| approval_date | 2026-01-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0.25MG/INH;EQ 0.05MG BASE/INH | POWDER;INHALATION |
| FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0.1MG/INH;EQ 0.05MG BASE/INH | POWDER;INHALATION |
2 products